Good news but IRB approval required for Germany, Spain and Finland sites as well, disappointing price action reminiscent of the ASX days.
- Forums
- ASX - By Stock
- IHL
- News: IHL Incannex Healthcare Receives IRB Approval For Reposa Phase 2/3 Clinical Trial Protocol
News: IHL Incannex Healthcare Receives IRB Approval For Reposa Phase 2/3 Clinical Trial Protocol, page-6
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)